Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer

This publication has 26 references indexed in Scilit:

• Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
  Journal of Clinical Oncology, 1995
• Effects of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Myelosuppression induced by Multiple Cycles of High-Dose Chemotherapy in Patients With Advanced Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
  New England Journal of Medicine, 1991
• Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung.
  Journal of Clinical Oncology, 1991
• Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study
  European Journal of Cancer and Clinical Oncology, 1991
• Prevention of infections in neutropenic patients with pefloxacin
  Journal of Antimicrobial Chemotherapy, 1990
• Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.
  Journal of Clinical Oncology, 1985
• The importance of dose intensity in chemotherapy of metastatic breast cancer.
  Journal of Clinical Oncology, 1984
• Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation
  Annals of Internal Medicine, 1984
• Reporting results of cancer treatment
  Cancer, 1981